|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pastushenko I, Brisebarre A, Sifrim A,
Fioramonti M, Revenco T, Boumahdi S, Van Keymeulen A, Brown D,
Moers V, Lemaire S, et al: Identification of the tumour transition
states occurring during EMT. Nature. 556:463–468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Said NA and Williams ED: Growth factors in
induction of epithelial-mesenchymal transition and metastasis.
Cells Tissues Organs. 193:85–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xing S, Yu W, Zhang X, Luo Y, Lei Z, Huang
D, Lin J, Huang Y, Huang S, Nong F, et al: Isoviolanthin extracted
from dendrobium officinale reverses TGF-β1-mediated
epithelial-mesenchymal transition in hepatocellular carcinoma cells
via deactivating the TGF-β/Smad and PI3K/Akt/mTOR signaling
pathways. Int J Mol Sci. 19(pii): E15562018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fantozzi A, Gruber DC, Pisarsky L, Heck C,
Kunita A, Yilmaz M, Meyer-Schaller N, Cornille K, Hopfer U,
Bentires-Alj M and Christofori G: VEGF-mediated angiogenesis links
EMT-induced cancer stemness to tumor initiation. Cancer Res.
74:1566–1575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mori S, Kodaira M, Ito A, Okazaki M,
Kawaguchi N, Hamada Y, Takada Y and Matsuura N: Enhanced expression
of integrin αvβ3 induced by TGF-β Is required for the enhancing
effect of fibroblast growth factor 1 (FGF1) in TGF-β-induced
epithelial-mesenchymal transition (EMT) in mammary epithelial
cells. PLoS One. 10:e01374862015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grassi ML, Palma CS, Thome CH, Lanfredi
GP, Poersch A and Faca VM: Proteomic analysis of ovarian cancer
cells during epithelial-mesenchymal transition (EMT) induced by
epidermal growth factor (EGF) reveals mechanisms of cell cycle
control. J Proteomics. 151:2–11. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stewart TA, Azimi I, Brooks AJ, Thompson
EW, Roberts-Thomson SJ and Monteith GR: Janus kinases and Src
family kinases in the regulation of EGF-induced vimentin expression
in MDA-MB-468 breast cancer cells. Int J Biochem Cell Biol.
76:64–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyazono K: Transforming growth
factor-beta signaling in epithelial-mesenchymal transition and
progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci.
85:314–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren W, Zhang Y, Zhang L, Lin Q, Zhang J
and Xu G: Overexpression of collagen type V α1 chain in human
breast invasive ductal carcinoma is mediated by TGF-β1. Int J
Oncol. Mar 15–2018.(Epub ahead of print). View Article : Google Scholar
|
|
14
|
Li ZM, Xu SW and Liu PQ: Salvia
miltiorrhiza Burge (Danshen): A golden herbal medicine in
cardiovascular therapeutics. Acta Pharmacol Sin. 39:802–824. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang L, Zhu J, Zheng M, Zou R, Zhou Y and
Zhu M: Tanshinone IIA protects against subclinical
lipopolysaccharide induced cardiac fibrosis in mice through
inhibition of NADPH oxidase. Int Immunopharmacol. 60:59–63. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen W, Tang F, Xie B, Chen S, Huang H and
Liu P: Amelioration of atherosclerosis by tanshinone IIA in
hyperlipidemic rabbits through attenuation of oxidative stress. Eur
J Pharmacol. 674:359–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao S, Liu Z, Li H, Little PJ, Liu P and
Xu S: Cardiovascular actions and therapeutic potential of
tanshinone IIA. Atherosclerosis. 220:3–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu BL, Li J, Zhou J, Li WW and Wu HF:
Tanshinone IIA decreases the levels of inflammation induced by
Aβ1–42 in brain tissues of Alzheimer's disease model rats.
Neuroreport. 27:883–893. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao YF, Wang SF, Li X, Zhang YL and Qiao
YJ: The anticancer mechanism investigation of Tanshinone
IIA by pharmacological clustering in protein network.
BMC Syst Biol. 12:902018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu YQ, Wang BY, Wu F, An YK and Zhou XQ:
Influence of tanshinone IIA on the apoptosis of human esophageal
Ec-109 cells. Nat Prod Commun. 11:17–19. 2016.PubMed/NCBI
|
|
21
|
He L and Gu K: Tanshinone IIA regulates
colorectal cancer apoptosis via attenuation of Parkin-mediated
mitophagy by suppressing AMPK/Skp2 pathways. Mol Med Rep.
18:1692–1703. 2018.PubMed/NCBI
|
|
22
|
Su CC, Chien SY, Kuo SJ, Chen YL, Cheng CY
and Chen DR: Tanshinone IIA inhibits human breast cancer MDA-MB-231
cells by decreasing LC3-II, Erb-B2 and NF-κBp65. Mol Med Rep.
5:1019–1022. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim EO, Kang SE, Im CR, Lee JH, Ahn KS,
Yang WM, Um JY, Lee SG and Yun M: Tanshinone IIA induces TRAIL
sensitization of human lung cancer cells through selective ER
stress induction. Int J Oncol. 48:2205–2212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin CY, Chang TW, Hsieh WH, Hung MC, Lin
IH, Lai SC and Tzeng YJ: Simultaneous induction of apoptosis and
necroptosis by Tanshinone IIA in human hepatocellular carcinoma
HepG2 cells. Cell Death Discov. 2:160652016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin J, Shi H, Xu Y, Zhao F and Wang Q:
Tanshinone IIA inhibits cervix carcinoma stem cells migration and
invasion via inhibiting YAP transcriptional activity. Biomed
Pharmacother. 105:758–765. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang SY, Chang SF, Liao KF and Chiu SC:
Tanshinone IIA inhibits epithelial-mesenchymal transition in
bladder cancer cells via modulation of STAT3-CCL2 signaling. Int J
Mol Sci. 18(pii): E16162017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou M, Zhou G, Hu S and Zhang L:
Tanshinone IIA suppress the proliferation of HNE-1 nasopharyngeal
carcinoma an in vitro study. Saudi J Biol Sci. 25:267–272. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu H, He Y, Qi L, Chen L, Luo Y, Chen L,
Li Y, Zhang N and Guo H: cPLA2α activates PI3K/AKT and inhibits
Smad2/3 during epithelial-mesenchymal transition of hepatocellular
carcinoma cells. Cancer Lett. 403:260–270. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xing S, Zhang X, Ke H, Lin J, Huang Y and
Wei G: Physicochemical properties of polysaccharides from
Dendrobium officinale by fractional precipitation and their
preliminary antioxidant and anti-HepG2 cells activities in vitro.
Chem Cent J. 12:1002018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng Z, Wei W, Wu Z, Wang J, Ding X,
Sheng Y, Han Y and Wu Q: ARPC2 promotes breast cancer proliferation
and metastasis. Oncol Rep. 41:3189–3200. 2019.PubMed/NCBI
|
|
31
|
Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han
Y, Yin L, Cai C, Guo C and Shen H: The anti-tumor activities of
Neferine on cell invasion and oxaliplatin sensitivity regulated by
EMT via Snail signaling in hepatocellular carcinoma. Sci Rep.
7:416162017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gore J, Deitz SL, Wilson JL and Korc M:
Abstract 969: TGF-beta cross-talks with the EGF receptor family to
promote proliferation of pancreatic cancer cells with dysfunctional
RB. Cancer Res. 74:9692014.
|
|
33
|
Xu ZH, Jiang YY, Steed H, Davidge S and Fu
YX: TGFβ and EGF synergistically induce a more invasive phenotype
of epithelial ovarian cancer cells. Biochem Biophys Res Commun.
401:376–381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wendt MK, Allington TM and Schiemann WP:
Mechanisms of the epithelial-mesenchymal transition by TGF-beta.
Future Oncol. 5:1145–1168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu ZM, Ghosh S, Wang ZY and Hunter T:
Downregulation of caveolin-1 function by EGF leads to the loss of
E-cadherin, increased transcriptional activity of beta-catenin, and
enhanced tumor cell invasion. Cancer Cell. 4:499–515. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu S and Liu P: Tanshinone II-A: New
perspectives for old remedies. Expert Opin Ther Pat. 23:149–153.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jeon YJ, Kim JS, Hwang GH, Wu Z, Han HJ,
Park SH, Chang W, Kim LK, Lee YM, Liu KH and Lee MY: Inhibition of
cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death
in hepatocellular carcinoma HepG2 cells. Eur J Pharmacol.
764:480–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ren X, Wang C, Xie B, Hu L, Chai H, Ding
L, Tang L, Xia Y and Dou X: Tanshinone IIA induced cell death via
miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular
carcinoma cells. Eur J Pharmacol. 796:233–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dong W, Zhang Y, Chen X and Jia Y:
High-dose tanshinone iia suppresses migration and proliferation
while promoting apoptosis of astrocytoma cells via Notch-1 pathway.
Neurochem Res. 43:1855–1861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Duan H, Ma L, Liu H, Zhang Y, Zhang Z, Yan
X and Li X: Tanshinone IIA attenuates epithelial-mesenchymal
transition to inhibit the tracheal narrowing. J Surg Res.
206:252–262. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pan M, Schinke H, Luxenburger E, Kranz G,
Shakhtour J, Libl D, Huang Y, Gaber A, Pavšič M, Lenarčič B, et al:
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts
EGF-mediated epithelial-mesenchymal transition through modulation
of phospho-ERK1/2 in head and neck cancers. PLoS Biol.
16:e20066242018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sheng W, Chen C, Dong M, Wang G, Zhou J,
Song H, Li Y, Zhang J and Ding S: Calreticulin promotes EGF-induced
EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling
pathway. Cell Death Dis. 8:e31472017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bhat FA, Sharmila G, Balakrishnan S,
Arunkumar R, Elumalai P, Suganya S, Raja Singh P, Srinivasan N and
Arunakaran J: Quercetin reverses EGF-induced epithelial to
mesenchymal transition and invasiveness in prostate cancer (PC-3)
cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem. 25:1132–1139.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tsai PC, Fu YS, Chang LS and Lin SR:
Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated
epithelial-to-mesenchymal transition and invasion of human breast
cancer MDA-MB-231 cells. Toxicon. 111:108–120. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu Z, Kuang W, Zhou Q and Zhang Y: TGF-β1
secreted by M2 phenotype macrophages enhances the stemness and
migration of glioma cells via the SMAD2/3 signalling pathway. Int J
Mol Med. 42:3395–3403. 2018.PubMed/NCBI
|
|
46
|
Ouanouki A, Lamy S and Annabi B:
Anthocyanidins inhibit epithelial-mesenchymal transition through a
TGFβ/Smad2 signaling pathway in glioblastoma cells. Mol Carcinog.
56:1088–1099. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pei Z, Fu W and Wang G: A natural product
toosendanin inhibits epithelial-mesenchymal transition and tumor
growth in pancreatic cancer via deactivating Akt/mTOR signaling.
Biochem Biophys Res Commun. 493:455–460. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Han S, Bui NT, Ho MT, Kim YM, Cho M and
Shin DB: Dexamethasone inhibits TGF-β1-induced cell migration by
regulating the ERK and AKT pathways in human colon cancer cells Via
CYR61. Cancer Res Treat. 48:1141–1153. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Fuxe J, Vincent T and Garcia de Herreros
A: Transcriptional crosstalk between TGF-β and stem cell pathways
in tumor cell invasion: Role of EMT promoting Smad complexes. Cell
Cycle. 9:2363–2374. 2010. View Article : Google Scholar : PubMed/NCBI
|
